Bafna Pharma

Chennai, India Founded: 1981 • Age: 45 yrs
Provider of formulation services for pharmaceutical industry
Annual revenue $17.1M Latest available
Total funding - Funding intelligence
Employees 406 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Bafna Pharma

Bafna Pharma is a company based in Chennai (India) founded in 1981. The company has 406 employees as of March 31, 2024. Bafna Pharma operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.

  • Headquarter Chennai, India
  • Employees 406 as on 31 Mar, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Bafna Pharmaceuticals Limited
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $17.09 M (USD)
    -4.33
    as on Mar 31, 2025
  • Net Profit
    $485.99 K (USD)
    -43.49
    as on Mar 31, 2025
  • EBITDA
    $1.34 M (USD)
    0.75
    as on Mar 31, 2025
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    406

    as on Mar 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Bafna Pharma

Bafna Pharma is a publicly listed company on the NSE with ticker symbol BAFNAPH in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: BAFNAPH · Sector: Health technology · India

Funding Insights of Bafna Pharma

Premium access

Detailed funding history for Bafna Pharma

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Bafna Pharma

Investments
Premium access

Investment portfolio details for Bafna Pharma

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Bafna Pharma

Premium access

Detailed financials for Bafna Pharma

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Bafna Pharma Comparisons

Bafna Pharma Primary company
Description
Provider of formulation services for pharmaceutical industry
Location
Chennai, India
Founded Year
1981
Annual Revenue
$17.09 M (USD)
Net Profit
$485.99 K (USD)
EBITDA
$1.34 M (USD)
Employees
406
As of 2024
Premium access

Peer comparison for Bafna Pharma

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Bafna Pharma

Bafna Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
CDMO focusing on spectrum of dosage forms and therapeutic segments
Locked Locked Locked
Company offering a suite of R&D and manufacturing services for small molecules and generics
Locked Locked Locked
Pharmaceutical development and manufacturing services are offered contractually.
Locked Locked Locked
Contract development and manufacturing organization for proprietary and generic drugs
Locked Locked Locked
Cephalosporin APIs and generic formulations are manufactured.
Locked Locked Locked
CDMO with a focus on early phase drug product development
Premium access

Detailed competitors of Bafna Pharma

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Bafna Pharma

Premium access

Complete news archive for Bafna Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bafna Pharma

Bafna Pharma was founded in 1981.

Bafna Pharma is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

As of Mar 31, 2024, the latest employee count at Bafna Pharma is 406.

Annual revenue of Bafna Pharma is $17.09M as on Mar 31, 2025.

Bafna Pharma was established in 1981 in Chennai, India, within the pharmaceutical sector. Manufacturing services focused on formulations are offered, with emphasis on exports to regulated and rest-of-world markets. Domestic operations were initiated in 2011 through the acquisition and launch of Raricap, targeting gynaec and paediatric segments. The company operates from its base in India to serve global and local needs.

Bafna Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Yes, Bafna Pharma is publicly traded on NSE under the ticker symbol BAFNAPH.

The ticker symbol of Bafna Pharma is BAFNAPH on NSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available